Navigation Links
Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures
Date:8/3/2010

SHANGHAI, Aug. 3 /PRNewswire-Asia/ -- Sangon Biotech, a Shanghai based life science research service company, and Bio Basic Inc. (BBI), a Toronto based life science research service company, announced today the completion of a $10 million round of funding from Qiming Ventures. The company is using the funding to scale research & development, marketing and sales of its life science research tools including biochemical reagents, protein, antibody, research kit, DNA synthesis service, etc. to meet increasing demand.

David Qisong Wang, the founder and Chairman introduced: "Shanghai Sangon Biotechnology has become one of leaders in China's life sciences R&D services. Starting from Canada, BBI is growing rapidly and offering a breath of high quality products and services to customers worldwide through our direct sales and service team and distributors in 40 countries."

Regarding this recent financing, David added: "We started to consider raising one round from an investor who really knows our business and could be our true partner. Quite some investors approached us and we believe Qiming Ventures is the one. This investment validates our vision of accelerating life science research in a cost effective way.

"We are surprised that even before the investment was completed, Qiming Ventures had already begun to work with us. We are extremely pleased and happy to form this relationship with Qiming Ventures," Tracey, GM of Sangon, and Jennifer, GM of BBI, added.

Nisa Lin and William Hu from Qiming Venture Partners joined the Board. The investors said: "We are very excited about the company's vision to build a world class life sciences research service company. We believe in the growing needs of research in a cost effective manner and are confident in the management team. We are very pleased to close this investment."

About Sangon & BBI:

Founded in 2003, Shanghai Sangon Biotechnology is one of China's leaders in life sciences research and development services, providing chemical and biological reagents, DNA synthesis, molecular biology kit, protein, antibody, and laboratory consumables.

Based in Canada and with sales network in 40 countries, BBI provides life science research tools and services including Molecular Biology Kits, Biochemicals, Synthetic Genes and Synthetic Oligos to customers worldwide.

About Qiming Ventures:

Qiming Venture Partners is a leading early to growth stage venture capital firm in China with offices in Shanghai, Beijing, Hong Kong and Seattle. Qiming and its affiliate in the US, Ignition Partners, together manage over $2.5 billion including two funds with $520 million under China management. Qiming invests in entrepreneurs creating the next generation of consumer, information technology, health care, and cleantech companies. Our partners are proven business leaders with strong operational experience and successful investment track records including many successful IPO's and merger and acquisition transactions in both the U.S and China. While striving to be the investor of choice, Qiming will work also closely with other leading venture capital firms in China to deliver the investor value that young Chinese companies require.


'/>"/>
SOURCE Qiming Venture Partners
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA CONSUMER HEALTH INFORMATION - Combating Misuse and Abuse of Prescription Drugs: Q&A with Michael Klein, Ph.D.
2. FDA Clears AirStrip RPM for CRITICAL CARE & CARDIOLOGY Remote Patient Monitoring Solutions
3. Clayton, Dubilier & Rice and GS Capital Partners Announce Acquisition of HGI Holdings, Inc., a Leading Medical Supplies Distributor
4. Diplomat Specialty Pharmacy Hires Senior Director of HR & Government Relations
5. Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership
6. Reminder: ADVENTRX Presents Today at the Lippert/Heilshorn Life Sciences & MedTech Virtual Conference
7. Childers, Schlueter & Smith, LLC Set for Reglan/metoclopramide Jury Trial Involving Womans Development of Tardive Dyskinesia
8. New Product Planning Plays a Critical Role for Future Research & Development Success
9. Adjusting Market Research Structures and Activities to Maximize Payer Access & Insights
10. Draeger Announces Partnership With L. N. Curtis & sons to Distribute Emergency Responder Equipment
11. Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2, 2016 Research and Markets has announced ... Growth and Demand Forecast to 2022" report to their offering. ... , , ... in 2015, and it is expected to grow at a CAGR of ... to witness faster growth during the forecast period, a CAGR of 8.8% ...
(Date:12/2/2016)... Dec. 2, 2016 In the first ever ... from those derived from C. sativa, the Hebrew University ... di Napoli Federico II , the Universita` del Piemonte ... comprehensive, critical, integrated and unified inventory of phytocannabinoids of ... focuses on the remarkable chemical and structural diversity of ...
(Date:12/2/2016)... , Dec. 2, 2016  Maxor National Pharmacy Services, ... of Pharmaceutical Specialties, Inc. ("PSI").  The combination of ... Georgia -based PSI bring together both company,s clinical ... manufacturers, and payers an industry-leading specialty pharmacy. About ... , , ...
Breaking Medicine Technology:
(Date:12/5/2016)... , ... December 05, 2016 , ... ... today that they have teamed up with The American College of Surgeons (ACS) ... ACS’s Committee on Trauma, the “Bleeding Control Basic” course is a pilot program ...
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... Tasting Event in New York City, with long-time partners The Paul Foundation, on ...
(Date:12/4/2016)... ... December 03, 2016 , ... Houston ... the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging Medicine ... Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, speakers, ...
(Date:12/4/2016)... ... December 04, 2016 , ... ... cosmetic surgery can now take advantage of a cosmetic procedure known as ... treatment that reduces the appearance of age spots, fine lines, uneven coloration, ...
(Date:12/2/2016)... ... December 02, 2016 , ... Halfway through its partnership with First 5 ... services to more than 15,900 children 5 years old and younger and treatment services ... over a span of five years to Western University of Health Sciences, UCLA and ...
Breaking Medicine News(10 mins):